Cargando…

Bendamustine/obinutuzumab: COVID-19 disease, pancytopenia and hypogammaglobulinaemia: case report

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435190/ http://dx.doi.org/10.1007/s40278-021-02017-2

Ejemplares similares

Tisagenlecleucel: Hypogammaglobulinaemia and pancytopenia: case report
Publicado: (2021)

Bendamustine/remdesivir/rituximab: Lymphocytopenia, hypogammaglobulinaemia and rebound viral shedding following drug resistance: case report
Publicado: (2022)

Prolonged COVID-19 in an Immunocompromised Patient Treated with Obinutuzumab and Bendamustine for Follicular Lymphoma
por: Ueda, Yayoi, et al.
Publicado: (2022)

Rituximab: Hypogammaglobulinaemia and recurrent COVID-19 infection: case report
Publicado: (2022)

Rituximab: Hypogammaglobulinaemia: 2 case reports
Publicado: (2021)

Bendamustine/ciclesonide/obinutuzumab: Diarrhoea following off-label use and prolonged viral shedding: case report
Publicado: (2021)

Multiple drugs: Prolonged course of COVID 19 infection and hypogammaglobulinaemia: case report
Publicado: (2022)

Bendamustine/obinutuzumab/remdesivir: Absence of CD19-B lymphocytes, decrease in CD4-T lymphocytes and lack of efficacy: case report
Publicado: (2021)

Recurrent COVID‐19 infection in a case of rituximab‐induced hypogammaglobulinaemia
por: Daniel, Jefferson, et al.
Publicado: (2021)

Prolonged SARS‐CoV‐2 infection during obinutuzumab and bendamustine treatment for follicular lymphoma: A case report
por: Kambe, Ryosuke, et al.
Publicado: (2023)

Multiple drugs: COVID-19 pneumonia secondary to hypogammaglobulinaemia and off-label use: case report
Publicado: (2022)

Case report of Ureaplasma urealyticum meningitis in a patient with thymoma and hypogammaglobulinaemia
por: Zhang, Ting, et al.
Publicado: (2021)

MRD response in relapsed/refractory FL after obinutuzumab plus bendamustine or bendamustine alone in the GADOLIN trial
por: Pott, Christiane, et al.
Publicado: (2019)

Safety and efficacy of obinutuzumab with CHOP or bendamustine in previously untreated follicular lymphoma
por: Grigg, Andrew, et al.
Publicado: (2017)

Safety and efficacy of atezolizumab with obinutuzumab and bendamustine in previously untreated follicular lymphoma
por: Younes, Anas, et al.
Publicado: (2022)

Bendamustine/rituximab: COVID-19 pneumonia: case report
Publicado: (2021)

Dementia in a patient with Thymoma and hypogammaglobulinaemia (Good's syndrome)
por: de Jesus, Nelson Pedro Ferreira, et al.
Publicado: (2008)

Thymoma associated with hypogammaglobulinaemia and pure red cell aplasia
por: Briones, Juan, et al.
Publicado: (2013)

Correlation of hypogammaglobulinaemia with proteinuria, and the relationship between hypogammaglobulinaemia and infection in active lupus nephritis
por: Smilek, Dawn Elaine, et al.
Publicado: (2017)

Persistent SARS-CoV-2 infection with multiple clinical relapses in two patients with follicular lymphoma treated with bendamustine and obinutuzumab or rituximab
por: Franceschini, Erica, et al.
Publicado: (2023)

Venetoclax plus bendamustine-rituximab or bendamustine-obinutuzumab in chronic lymphocytic leukemia: final results of a phase Ib study (GO28440)
por: Stilgenbauer, Stephan, et al.
Publicado: (2020)

Obinutuzumab: B-cell depletion: case report
Publicado: (2021)

A Case of Turner Syndrome with Concomitant Transient Hypogammaglobulinaemia of Infancy and Central Diabetes Insipidus
por: Korkmaz, Hüseyin Anıl, et al.
Publicado: (2013)

Good's syndrome: Thymoma with hypogammaglobulinaemia
por: Mathew, Anoop, et al.
Publicado: (2020)

Obinutuzumab/rituximab: Decreased platelet count and chronic COVID-19 pneumonia: case report
Publicado: (2020)

Obinutuzumab plus bendamustine in previously untreated patients with CLL: a subgroup analysis of the GREEN study
por: Stilgenbauer, Stephan, et al.
Publicado: (2018)

Daratumumab/obinutuzumab: Various toxicities: 14 case reports
Publicado: (2021)

Cisplatin/gemcitabine: Pancytopenia: case report
Publicado: (2021)

Multiple drugs: Pancytopenia, COVID-19 and off-label use: case report
Publicado: (2020)

Bendamustine/dexamethasone/rituximab: Cytomegalovirus reactivation : case report
Publicado: (2021)

Bendamustine/rituximab: Neutropenia, fever and inflammation: case report
Publicado: (2022)

Graves Disease Causing Pancytopenia: Case Report and Literature Review
por: Pincet, Laurence, et al.
Publicado: (2018)

Dasatinib: COVID-19 pneuminia, febrile neutropenia, pancytopenia and pleural effusion: case report
Publicado: (2020)

Correction to: Case report of Ureaplasma urealyticum meningitis in a patient with thymoma and hypogammaglobulinaemia
por: Zhang, Ting, et al.
Publicado: (2021)

Three cases of alloimmune mediated pancytopenia in calves resembling bovine neonatal pancytopenia
por: Chantillon, L., et al.
Publicado: (2022)

Bendamustine-induced nephrogenic diabetes insipidus – A case report
por: Desjardins, Audrey, et al.
Publicado: (2021)

Pancytopenia related to Graves’ disease
por: Hegazi, Mohammed, et al.
Publicado: (2008)

Antineoplastics: Pancytopenia and off-label use: case report
Publicado: (2020)

Pancytopenia with Development of Persistent Neutropenia Secondary to COVID-19
por: Wu, Kathie, et al.
Publicado: (2022)

Health-related quality of life and symptoms in patients with rituximab-refractory indolent non-Hodgkin lymphoma treated in the phase III GADOLIN study with obinutuzumab plus bendamustine versus bendamustine alone
por: Cheson, Bruce D., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_5attrk1dicv72ust5unv6mf3fg